FMR1 CGG Repeats

Abstract

FMR1 premutation carriers (55-199 CGG repeats), and potentially women with high normal (35-44) or low normal (<28) CGG repeats, are at risk of premature ovarian aging. The scarcity of population data on CGG repeats <45 CGG, and variation in race–ethnicity, makes it difficult to determine true associations. DNA was analyzed for FMR1 CGG repeat lengths from 803 women (386 caucasians, 219 African Americans, 102 Japanese, and 96 Chinese) from the US-based Study of Women’s Health Across the Nation (SWAN). Participants had ≥1 menses in the 3 months before enrollment, ≥1 pregnancy, no history of infertility or hormonal therapy, and menopause ≥46 years. Statistical analyses used Fisher exact tests. Among these women with normal reproductive histories, significant FMR1 repeat length differences were found across race-ethnicity for both the longer (P = .0002) and the shorter (P < .0001) alleles. The trinucleotide length variance was greater for non-Asian than Asian women (P < .0001), despite identical median values. Our data indicate that short allele lengths <25 CGG on one or both alleles are more common in non-Asian than Asian women. We confirm the minor allele in the 35 to 39 CGG range among Asians as reported previously. Only 2 (0.3%) premutation carriers were identified. These data demonstrate that FMR1 distributions do vary by race–ethnicity, even within the “normal” range. This study indicates the need to control for race–ethnicity in FMR1 ovarian aging research and provides race–ethnic population data for females separated by allele.

Keywords

race–ethnicity genetic variation diminished ovarian reserve women primary ovarian insufficiency reference population

Get full access to this article

View all access options for this article.

References

Allingham-Hawkins

Babul-Hirji

Chitayat

. Fragile X premutation is a significant risk factor for premature ovarian failure: the International Collaborative POF in Fragile X study—preliminary data. Am J Med Genet. 1999;83(4):322–325.

Uzielli

Guarducci

Lapi

. Premature ovarian failure (POF) and fragile X premutation females: from POF to to fragile X carrier identification, from fragile X carrier diagnosis to POF association data. Am J Med Genet. 1999;84(3):300–303.

Sullivan

Marcus

Epstein

. Association of FMR1 repeat size with ovarian dysfunction. Hum Reprod. 2005;20(2):402–412.

Streuli

Fraisse

Ibecheole

Moix

Morris

de Ziegler

. Intermediate and premutation FMR1 alleles in women with occult primary ovarian insufficiency. Fertil Steril. 2009;92(2):464–470.

Pastore

Young

Baker

Karns

Williams

Silverman

. Elevated prevalence of 35-44 FMR1 trinucleotide repeats in women with diminished ovarian reserve. Reprod Sci. 2012;19(11):1226–1231.

Bretherick

Fluker

Robinson

. FMR1 repeat sizes in the gray zone and high end of the normal range are associated with premature ovarian failure. Hum Genet. 2005;117(4):376–382.

Gleicher

Weghofer

Oktay

Barad

. Relevance of triple CGG repeats in the FMR1 gene to ovarian reserve. Reprod Biomed Online. 2009;19(3):385–390.

Pastore

Johnson

. The FMR1 gene, infertility and reproductive decision-making: a review. Front Genet. 2014;5:195.

Kim

Kim do

Kim

. Fragile X carrier screening in Korean women of reproductive age. J Med Screen. 2013;20(1):15–20.

10.

Voorhuis

Onland-Moret

Janse

. The significance of fragile X mental retardation gene 1 CGG repeat sizes in the normal and intermediate range in women with primary ovarian insufficiency. Hum Reprod. 2014;29(7):1585–1593.

11.

Weiss

Orr-Urtreger

Kaplan Ber

. Ethnic effect on FMR1 carrier rate and AGG repeat interruptions among Ashkenazi women. Genet Med. 2014;16(12):940–944.

12.

Falik-Zaccai

Shachak

Yalon

. Predisposition to the fragile X syndrome in Jews of Tunisian descent is due to the absence of AGG interruptions on a rare Mediterranean haplotype. Am J Hum Genet. 1997;60(1):103–112.

13.

Fernandez-Carvajal

Walichiewicz

Xiaosen

Pan

Hagerman

Tassone

. Screening for expanded alleles of the FMR1 gene in blood spots from newborn males in a Spanish population. J Mol Diagn. 2009;11(4):324–329.

14.

Richards

Kondo

Holman

. Haplotype analysis at the FRAXA locus in the Japanese population. Am J Med Genet. 1994;51(4):412–416.

15.

Crawford

Meadows

Newman

. Prevalence of the fragile X syndrome in African-Americans. Am J Med Genet. 2002;110(3):226–233.

16.

Dawson

Chodirker

Chudley

. Frequency of FMR1 premutations in a consecutive newborn population by PCR screening of Guthrie blood spots. Biochem Mol Med. 1995;56(1):63–69.

17.

Y-H

Kuhl

DPA

Pizzuti

. Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell. 1991;67(6):1047–1058.

18.

Huang

Xia

Luo

. Distribution of fragile X mental retardation 1 CGG repeat and flanking haplotypes in a large Chinese population. Mol Genet Genomic Med. 2015;3(3):172–181.

19.

Otsuka

Sakamoto

Siomi

. Fragile X carrier screening and FMR1 allele distribution in the Japanese population. Brain Dev. 2010;32(2):110–114.

20.

Strom

Crossley

Redman

. Molecular testing for fragile X syndrome: lessons learned from 119,232 tests performed in a clinical laboratory. Genet Med. 2007;9(1):46–51.

21.

Tzeng

Cho

Kuo

Chen

. Pilot fragile X screening in normal population of Taiwan. Diagn Mol Pathol. 1999;8(3):152–156.

22.

Genereux

Laird

. Why do fragile X carrier frequencies differ between Asian and non-Asian populations? Genes Genet Syst. 2013;88(3):211–224.

23.

Crawford

Zhang

Wilson

Warren

Sherman

. Fragile X CGG repeat structures among African-Americans: identification of a novel factor responsible for repeat instability. Hum Mol Genet. 2000;9(12):1759–1769.

24.

Eichler

Macpherson

Murray

Jacobs

Chakravarti

Nelson

. Haplotype and interspersion analysis of the FMR1 CGG repeat identifies two different mutational pathways for the origin of the fragile X syndrome. Hum Mol Genet. 1996;5(3):319–330.

25.

Faradz

Pattiiha

Leigh

. Genetic diversity at the FMR1 locus in the Indonesian population. Ann Hum Genet. 2000;64(pt 4):329–339.

26.

Kronquist

Sherman

Spector

. Clinical significance of tri-nucleotide repeats in fragile X testing: a clarification of American College of Medical Genetics guidelines. Genet Med. 2008;10(11):845–847.

27.

Biancalana

Glaeser

McQuaid

Steinbach

. EMQN best practice guidelines for the molecular genetic testing and reporting of fragile X syndrome and other fragile X-associated disorders. Eur J Hum Genet. 2015;23(4):417–425.

28.

Sowers

Crawford

Sternfeld

. SWAN: a multicenter, multiethnic, community-based cohort study of women and the menopausal transition. In: Lobo

Kelsey

Marcus

, eds. Menopause: Biology and Pathobiology. San Diego, CA: Academic Press; 2000:175–188.

29.

Kardia

Chu

Sowers

. Characterizing variation in sex steroid hormone pathway genes in women of 4 races/ethnicities: the Study of Women’s Health Across the Nation (SWAN). Am J Med. 2006;119(9 suppl 1):s3–s15.

30.

Murray

Schoemaker

Bennett

. Population-based estimates of the prevalence of FMR1 expansion mutations in women with early menopause and primary ovarian insufficiency. Genet Med. 2014;16(1):19–24.

31.

White

Ayad

Fraser

. A 6-year experience demonstrates the utility of screening for both cytogenetic and FMR-1 abnormalities in patients with mental retardation. Genet Test. 1999;3(3):291–296.

32.

Larsen

Grønskov

Nørgaard-Pedersen

Brøndum-Nielsen

Hasholt

Vuust

. High-throughput analysis of Fragile X (CGG)n alleles in the normal and premutation range by PCR amplification and automated capillary electrophoresis. Hum Genet. 1997;100(5-6):564–568.

33.

Nolin

Glicksman

Ding

. Fragile X analysis of 1112 prenatal samples from 1991 to 2010. Prenat Diagn. 2011;31(10):925–931.

34.

Gleicher

Kim

Weghofer

Barad

. Differences in ovarian aging patterns between races are associated with ovarian genotypes and sub-genotypes of the FMR1 gene. Reprod Biol Endocrinol. 2012;10:77.

35.

Yrigollen

Sweha

Durbin-Johnson

. Distribution of AGG interruption patterns within nine world populations. Intractable Rare Dis Res. 2014;3(4):153–161.

36.

Cronister

Teicher

Rohlfs

Donnenfeld

Hallam

. Prevalence and instability of fragile X alleles: implications for offering fragile X prenatal diagnosis. Obstet Gynecol. 2008;111(3):596–601.

37.

Maenner

Baker

Broman

. FMR1 CGG expansions: prevalence and sex ratios. Am J Med Genet B Neuropsychiatr Genet. 2013;162b(5):466–473.

38.

Mailick

Hong

Rathouz

. Low-normal FMR1 CGG repeat length: phenotypic associations. Front Genet. 2014;5:309.

39.

Berkenstadt

Ries-Levavi

Cuckle

Peleg

Barkai

. Preconceptional and prenatal screening for fragile X syndrome: experience with 40,000 tests. Prenat Diagn. 2007;27(11):991–994.

40.

Musci

Caughey

. Cost-effectiveness analysis of prenatal population-based fragile X carrier screening. Am J Obstet Gynecol. 2005;192(6):1905–1912; discussion 1912-1915.

41.

Abrams

Cronister

Brown

. Newborn, carrier, and early childhood screening recommendations for fragile X. Pediatrics. 2012;130(6):1126–1135.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.02 MB